Current and future burden of breast cancer in Asia: A GLOBOCAN data analysis for 2022 and 2050.

ABSTRACT:

Background

Breast cancer remains a significant health concern in Asia. This study seeks to analyze the burden of breast cancer in Asia based on the most recent GLOBOCAN 2022 estimates.

Methods

Data were obtained from GLOBOCAN 2022. Age-standardized rates for incidence and mortality per 100,000 person-years were calculated using direct age standardization with the Segi-Doll World standard population. Pearson's correlation coefficient was utilized to evaluate the relationship between human development index and incidence or mortality rate. The future number of breast cancer cases and deaths by 2050 was estimated based on global demographic projections.

Results

In 2022, breast cancer accounted for 2296.8 thousand new cases and 666.1 thousand deaths worldwide. In Asia, an

SUBMITTER: Fu M 

PROVIDER: S-EPMC11609486 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature